The European–Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer (EULAT Eradicate GBC) is identifying geographical, environmental, lifestyle, genetic and molecular risk factors for gallbladder cancer. Collaborative research is essential to improve prevention of this aggressive tumour, especially in high-incidence, low-income and middle-income regions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Guzman, M., Canedo-Marroquin, G. & Jimenez-Vargas, N. N. Challenges in gastrointestinal research in Latin America. Nat. Rev. Gastroenterol. Hepatol. 20, 199–200 (2023).
Zollner, L. et al. Gallbladder cancer risk and Indigenous South American Mapuche ancestry: instrumental variable analysis using ancestry-informative markers. Cancers 15, 4033 (2023).
Boekstegers, F. et al. Gallbladder cancer and dysplasia in cholecystectomy specimens: a large study in high-incidence regions of South America. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2024.12.027 (2025).
Gonzalez, C. et al. Cholecystectomy and digestive cancer in Chile: complementary results from interrupted time series and aggregated data analyses. Int. J. Cancer 156, 91–103 (2024).
Roa, I., Ibacache, G., Muñoz, S. & de Aretxabala, X. Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases. Am. J. Clin. Pathol. 141, 675–682 (2014).
Zhu, X. et al. Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: a retrospective study based on SEER data. Medicine 99, e22292 (2020).
Blandino, A. et al. Identification of circulating lncRNAs associated with gallbladder cancer risk by tissue-based preselection, cis-eQTL validation, and analysis of association with genotype-based expression. Cancers 14, 634 (2022).
Brägelmann, J. et al. Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology 73, 2293–2310 (2021).
Boekstegers, F. et al. Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country. Int. J. Cancer 153, 1151–1161 (2023).
Barahona Ponce, C. et al. Gallstones, body mass index, C-reactive protein, and gallbladder cancer: Mendelian randomization analysis of Chilean and European genotype data. Hepatology 73, 1783–1796 (2021).
Kharazmi, E. et al. Gallstones, cholecystectomy, and kidney cancer: observational and Mendelian randomization results based on large cohorts. Gastroenterology 165, 218–227.e8 (2023).
Acknowledgements
The authors would like to thank all collaborators for their great commitment to the EULAT Eradicate GBC project; without their generous support this important project would not be possible. The project is supported by the European Union’s Horizon 2020 research and innovation programme (grant 825741).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
BBMRI-ERIC: https://www.bbmri-eric.eu/
CECAN: https://cecan.cl/
EULAT Eradicate GBC: www.SaludVesiculaBiliar.org
GECKO: www.globalsurgeryunit.org/clinical-trials-holding-page/project-gecko/
GLOBOCAN: https://gco.iarc.fr/en
Rights and permissions
About this article
Cite this article
Scherer, D., Kumar, R., Lorenzo Bermejo, J. et al. International collaborative research to improve gallbladder cancer prevention. Nat Rev Gastroenterol Hepatol 22, 293–294 (2025). https://doi.org/10.1038/s41575-025-01061-z
Published:
Issue date:
DOI: https://doi.org/10.1038/s41575-025-01061-z